MRK vs VRT: Which Is the Better Buy?

Side-by-side comparison of Merck & Co., Inc. and Vertiv Holdings Co β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
Merck & Co., Inc. Β· Healthcare
$147.17
-4.1% upside to fair value
Med Conviction Grade C
VS
Vertiv Holdings Co Β· Industrials
$253.28
+8.2% upside to fair value
Med Conviction Grade C High Quality
QuantHub Verdict
VRT has more upside to fair value (+8.2%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MRK VRT
Current Price $147.17 $253.28
Fair Value Estimate $141.07 $274.15
Upside to Fair Value -4.1% +8.2%
Market Cap $363.5B $97.5B
Forward P/E β€” β€”
EV / EBITDA 29.6x 38.8x
Price / Sales 5.5x 8.5x
Price / FCF 22.6x 33.3x
Revenue Growth YoY +5.1% +24.1%
Gross Margin 75.4% 37.5%
Operating Margin 16.7% 19.1%
Return on Equity 6.6% 42.1%
Dividend Yield 2.31% 0.1%
FCF Yield 4.42% 3.0%
Analyst Consensus Buy Strong Buy
Investment Thesis
MRK β€” Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
VRT β€” Vertiv Holdings Co
Vertiv Holdings Co is a global provider of critical digital infrastructure for data centers, communication networks, and industrial applications, spanning AC and DC power management, thermal cooling, integrated rack systems, and lifecycle services under brands including Liebert, NetSure, Geist, and Avocent, with roughly 34,000 employees and a global footprint across the Americas, Asia Pacific, an…
Accumulation Zones
Metric MRK VRT
Zone Low $105.80 $205.61
Zone High $119.91 $233.03
In Buy Zone? No No
← MRK Research    VRT Research β†’    All Research